Acasti Pharma, Inc. (ACST) SEC filings
ACST SEC filings moved a median of 0.00% by the close. ACST SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the ACST overview →
38 measured ACST SEC filing events.
Where these ACST SEC filings landedvs 27 measured ACST SEC filing reactions
| Middle 50% of ACST SEC filing reactions | -2.48% to +3.15% |
|---|---|
| Median reaction (to close) | 0.00% |
| Measured reactions | 27 |
Point-in-time · zero look-ahead
Half of the 27 ACST SEC filing events with a measured close landed between -2.48% and +3.15%; 48% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form EFFECT Grace Therapeutics, Inc. | SEC filing · Form EFFECT | — | — | |
| Form S-3 Grace Therapeutics, Inc. | SEC filing · Form S-3 | — | — | |
| Form 8-K Grace Therapeutics, Inc. For: Mar 03 | SEC filing · Form 8-K | — | — | |
| Form D Grace Therapeutics, Inc. | SEC filing · Form D | — | — | |
| Form 10-Q/A Grace Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-Q | — | — | |
| Form 10-Q Grace Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-Q | — | — | |
| Form 8-K Grace Therapeutics, Inc. For: Feb 13 | SEC filing · Form 8-K | — | — | |
| Form 8-K Grace Therapeutics, Inc. For: Feb 10 | SEC filing · Form 8-K | — | — | |
| Form 10-Q Grace Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | — | — | |
| Form 8-K Grace Therapeutics, Inc. For: Nov 13 | SEC filing · Form 8-K | — | — | |
| Form 8-K Grace Therapeutics, Inc. For: Oct 24 | SEC filing · Form 8-K | — | — | |
| Form 8-K Acasti Pharma Inc. For: Oct 25 | SEC filing · Form 8-K | +0.00% | -0.30% | |
| Form EFFECT Acasti Pharma Inc. | SEC filing · Form EFFECT | +0.00% | -0.30% | |
| Form POS AM Acasti Pharma Inc. | SEC filing · Form POS | — | -3.82% | |
| Form S-8 Acasti Pharma Inc. | SEC filing · Form S-8 | — | -3.82% | |
| Form S-8 POS Acasti Pharma Inc. | SEC filing · Form S-8 | — | -3.82% | |
| Form 8-K Acasti Pharma Inc. For: Oct 01 | SEC filing · Form 8-K | — | -3.82% | |
| Form 8-K Acasti Pharma Inc. For: Sep 30 | SEC filing · Form 8-K | — | -0.33% | |
| Form 8-K Acasti Pharma Inc. For: Sep 25 | SEC filing · Form 8-K | — | +18.61% | |
| Form DEFA14A Acasti Pharma Inc. | SEC filing · Form DEFA14A | +0.00% | +1.66% | |
| Form 8-K Acasti Pharma Inc. For: Aug 12 | SEC filing · Form 8-K | +0.00% | +3.32% | |
| Form 10-Q Acasti Pharma Inc. For: Jun 30 | SEC filing · Form 10-Q | -0.18% | -3.28% | |
| Form 8-K Acasti Pharma Inc. For: Aug 09 | SEC filing · Form 8-K | -0.18% | -3.28% | |
| Form DEFA14A Acasti Pharma Inc. | SEC filing · Form DEFA14A | — | +0.00% | |
| Form EFFECT Acasti Pharma Inc. | SEC filing · Form EFFECT | +0.00% | -3.46% | |
| Form S-4/A Acasti Pharma Inc. | SEC filing · Form S-4 | — | +0.37% | |
| Form 8-K Acasti Pharma Inc. For: Jun 27 | SEC filing · Form 8-K | — | -1.68% | |
| Form S-4 Acasti Pharma Inc. | SEC filing · Form S-4 | — | -1.68% | |
| Form 10-K Acasti Pharma Inc. For: Mar 31 | SEC filing · Form 10-K | +3.95% | +4.76% | |
| Form 8-K Acasti Pharma Inc. For: Jun 21 | SEC filing · Form 8-K | +3.95% | +4.76% | |
| Form 8-K Acasti Pharma Inc. For: Apr 01 | SEC filing · Form 8-K | +0.00% | +2.98% | |
| Form 10-Q Acasti Pharma Inc. For: Dec 31 | SEC filing · Form 10-Q | +0.00% | +6.97% | |
| Form 8-K Acasti Pharma Inc. For: Feb 12 | SEC filing · Form 8-K | +0.00% | +6.97% | |
| Form 8-K Acasti Pharma Inc. For: Jan 05 | SEC filing · Form 8-K | +0.00% | -0.69% | |
| Form 8-K Acasti Pharma Inc. For: Dec 11 | SEC filing · Form 8-K | +4.90% | +5.39% | |
| Form 10-Q Acasti Pharma Inc. For: Sep 30 | SEC filing · Form 10-Q | -1.40% | +0.47% | |
| Form 8-K Acasti Pharma Inc. For: Nov 13 | SEC filing · Form 8-K | -1.40% | +0.47% | |
| Form 8-K Acasti Pharma Inc. For: Oct 18 | SEC filing · Form 8-K | +0.00% | +1.70% |
Keep exploring
More ACST: earnings → · analyst actions → · ACST overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Trevena, Inc. (TRVN) | 91 | 0.00% | 46% |
| CV SCIENCES INC (CVSI) | 90 | +0.59% | 53% |
| Microbix Biosystems Inc (MBX_TSE) | 89 | 0.00% | 32% |
| VIVOS INC (RDGL) | 88 | 0.00% | 43% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.